Myriad Women's Health, Inc. Sustainability Profile
Myriad Women's Health, Inc., headquartered in the United States, is a leading player in the women's health industry, specialising in genetic testing and personalised medicine. Founded in 2018, the company has quickly established itself as a pioneer in providing innovative solutions for women's health issues, particularly in areas such as hereditary cancer risk assessment and reproductive health. With a focus on empowering women through advanced genetic insights, Myriad offers unique products like the Myriad myRisk® test, which assesses the risk of various cancers, and the Myriad Prequel® test for prenatal screening. These services are distinguished by their comprehensive approach and commitment to accuracy, helping healthcare providers make informed decisions. Recognised for its significant contributions to women's health, Myriad Women's Health continues to enhance its market position through ongoing research and development, aiming to improve health outcomes for women across the globe.
DitchCarbon Score
How does Myriad Women's Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Myriad Women's Health, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Myriad Women's Health, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a merged entity, and any potential emissions data may be inherited from its corporate family. However, there are no specific reduction targets or climate commitments outlined in the available information. As a merged entity, Myriad Women's Health, Inc. may align its climate strategies with broader industry standards, but specific initiatives or commitments have not been disclosed. The lack of reported emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate action framework. In the context of the industry, it is essential for organisations like Myriad Women's Health to establish clear carbon reduction targets and transparent reporting practices to contribute effectively to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 533,000,000 | 000,000 |
| Scope 2 | - | 000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Myriad Women's Health, Inc.'s Industry?
How Carbon Intensive is Myriad Women's Health, Inc.'s Location?
Myriad Women's Health, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Myriad Women's Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
